Profound Medical (PROF)
(Delayed Data from NSDQ)
$5.58 USD
-0.11 (-1.94%)
Updated Aug 5, 2025 03:59 PM ET
After-Market: $5.41 -0.17 (-3.05%) 7:58 PM ET
3-Hold of 5 3
F Value F Growth F Momentum F VGM
Fundamental Charts
About Market Cap
As of the previous market close, Profound Medical has a market cap of $171.01M, which represents its share price of $5.69 multiplied by its outstanding shares number of 30.05M. As a small-cap company, PROF's shareholders are generally exposed to more risk than shareholders of mid and large-cap companies.
The company's Market Capitalization is a measurement of company size. It is calculation of the company's share price times the number of outstanding shares. Large market cap companies give stability and are good long-term investments. Small market cap companies can produce faster growth and bigger returns, but their stockholders are exposed to more risk.
PROF 5.58 -0.11(-1.94%)
Will PROF be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for PROF based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for PROF
Madrigal (MDGL) Reports Q2 Loss, Tops Revenue Estimates
Profound Medical (PROF) Reports Q1 Loss, Misses Revenue Estimates
PROF: What are Zacks experts saying now?
Zacks Private Portfolio Services
Strength Seen in Profound Medical (PROF): Can Its 8.3% Jump Turn into More Strength?
Profound Medical (PROF) Reports Q4 Loss, Misses Revenue Estimates
Rigel Pharmaceuticals (RIGL) Surpasses Q4 Earnings and Revenue Estimates
Other News for PROF
Profound Medical to Release Second Quarter 2025 Financial Results on August 14 -- Conference ...
Profound Medical (PROF) Shares Cross Above 200 DMA
Profound Medical (PROF) Advances BPH Treatment with New Module | PROF Stock News
Profound Medical announces first commercial BPH treatment using TULSA-AI
Profound Medical announces first commercial BPH treatment using TULSA-AI